Flinton Capital Management’s Arvinas ARVN Stock Holding History

Flinton Capital Management’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-80	Closed	-$1K	–	877
2018 Q4	$1K	Buy	+80	New	+$1.27K	﹤0.01%	860

Other funds holding ARVN

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Flinton Capital Management's ARVN Position: Q1 2019 in Review

Flinton Capital Management sold out of Arvinas (ARVN) in Q1 2019, closing a stake of 80 shares — an estimated $1K sold.

Flinton Capital Management first reported a position in ARVN in Q4 2018 and held it in 1 quarter. The position peaked at $1K in Q4 2018. 57 funds tracked by Wall St. Rank hold ARVN as of Q1 2019.

Flinton Capital Management reported no remaining Arvinas position as of Q1 2019 after selling out during the quarter.
Flinton Capital Management sold 80 Arvinas shares in Q1 2019, an estimated $1K.
Flinton Capital Management first reported a position in Arvinas in Q4 2018 and held it in 1 quarter.
Flinton Capital Management's Arvinas position peaked at $1K in Q4 2018.
57 funds tracked by Wall St. Rank held Arvinas as of Q1 2019.

Based on Flinton Capital Management's 13F filing for Q1 2019, filed 13 May 2019.